|
| |
Demyelinating DiseasesDownload PDF 
Recent Publications on Demyelinating Diseases: |  |
Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination.
In the present work we analyzed the capacity of thyroid hormones (THs) to... | 24th June, 2008
| Departamento de Quimica Biologica, IQUIFIB and IIMHNO, Facultad de
| Exp Neurol. 2008 May 15;.
DOI Direct Link |
Exacerbation of autoimmune arthritis by copolymer-I through promoting type 1 immune response and autoantibody production.
Copolymer-I (COP-I) is an unique immune regulatory polymer that has been... | 24th June, 2008
| Department of Immunology, Baylor College of Medicine, Houston, TX 77030,
| Autoimmunity. 2008 Aug;41(5):363-71.
DOI Direct Link |
Tumor necrosis factor alpha mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present.
Reactive microglia and astrocytes are present in lesions of white matter... | 20th June, 2008
| Department of Neurology and the F. M. Kirby Neurobiology Center,
| J Neurosci. 2008 May 14;28(20):5321-30.
DOI Direct Link |
Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination.
The TAM family of receptor protein tyrosine kinases comprises three known... | 20th June, 2008
| Howard Florey Institute, University of Melbourne, Parkville, Victoria
| J Neurosci. 2008 May 14;28(20):5195-206.
DOI Direct Link |
A molecular genetic update of inherited distal motor neuropathies.
Inherited peripheral neuropathies belong to the most common neuromuscular... | 13th June, 2008
| Molecular Genetics Department, Flanders Interuniversity Institute for
| Verh K Acad Geneeskd Belg. 2008;70(1):25-46.
|
→View more research publications. |
Demyelinating Diseases Patents: |  |
| US Patent No. | Title |
| 7335358 | Methods of treating psoriasis with anti-TNF antibodies |
| 7345091 | Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
| 7345148 | Human G-protein coupled receptor, HGPRBMY29sv1 polypeptides |
| 7351566 | 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552, and 65577 molecules and uses therefor |
| 7354940 | 2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12 |
→View more patents. |
BioPortfolio Ltd. offers e-mail and postal lists for Demyelinating Diseases scientists - we have details of around 874 individuals working on Demyelinating Diseases .
This page has been viewed 73 times
Recent Search Terms used to find this page: Cytoskeletal transition at the paranodes | Cytoskeletal transition at the paranodes | mimicker of demyelinating disease | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Demyelinating Diseases across BioPortfolio, or bestselling Demyelinating Diseases books or recently published Demyelinating Diseases books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. |
